FDA Requires Labeling Change for Some Drugs Used to Prevent Rejection of Kidney Transplants
The U.S. Food and Drug Administration today said that it will require manufacturers of some immunosuppressant drugs used in kidney (renal) transplantation to update their labeling to reflect an increased risk of infections.